Cargando…

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a rare inherited kidney disorder with considerable symptom burden and negative effects even in early-stage disease. Patients’ reporting of ADPKD symptom burden may differ from physicians’ impressions. In this quantitative, cross-sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanon Aigbogun, Myrlene, Oberdhan, Dorothee, Doane, Michael J, Rooney, Jillian, Inyart, Brian C, Pao, Christina S, Denny, Alexis H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053527/
https://www.ncbi.nlm.nih.gov/pubmed/33880055
http://dx.doi.org/10.2147/IJNRD.S297491
_version_ 1783680140724666368
author Sanon Aigbogun, Myrlene
Oberdhan, Dorothee
Doane, Michael J
Rooney, Jillian
Inyart, Brian C
Pao, Christina S
Denny, Alexis H
author_facet Sanon Aigbogun, Myrlene
Oberdhan, Dorothee
Doane, Michael J
Rooney, Jillian
Inyart, Brian C
Pao, Christina S
Denny, Alexis H
author_sort Sanon Aigbogun, Myrlene
collection PubMed
description BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a rare inherited kidney disorder with considerable symptom burden and negative effects even in early-stage disease. Patients’ reporting of ADPKD symptom burden may differ from physicians’ impressions. In this quantitative, cross-section survey study, we evaluated patient and physician assessments of symptom burden at early- and late-stage ADPKD. METHODS: In the United States, 300 patients with ADPKD and 155 physicians treating patients with ADPKD completed online surveys administered by Kantar. Disease stage was categorized as early (chronic kidney disease [CKD] stages 1–3) or late (stages 4–5). Patients completed the Work Productivity and Activity Impairment Questionnaire and reported current disease symptoms. Patients and physicians assessed impacts of ADPKD on daily life and burden of specific symptoms. Statistical analyses compared patient versus physician responses stratified by early- versus late-stage ADPKD. RESULTS: We found that impairment in work productivity was statistically greater in late- versus early-stage CKD. Compared with physicians’ impressions, patients were more likely at early stages and less likely at later stages to report a moderate/strong impact of ADPKD on daily life. Among patients, 74% with early- and 88% with late-stage disease reported that ADPKD caused them to modify their daily lives. In early-stage disease, patients reported a statistically greater burden from feeling exhausted and less burden from dull kidney pain, cardiovascular problems, high blood pressure, and liver cysts than physicians assumed. At later stages, patients reported feeling exhausted and skeletal/joint pain as more burdensome, and frequent urination, high blood pressure, liver cysts, and hematuria as less burdensome, compared with physicians’ impressions. CONCLUSION: The results of this survey study demonstrate a disconnect between patients’ experiences and physicians’ awareness of the burden of ADPKD and highlight the need for more patient/physician discussion of symptoms and disease management.
format Online
Article
Text
id pubmed-8053527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80535272021-04-19 Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study Sanon Aigbogun, Myrlene Oberdhan, Dorothee Doane, Michael J Rooney, Jillian Inyart, Brian C Pao, Christina S Denny, Alexis H Int J Nephrol Renovasc Dis Original Research BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a rare inherited kidney disorder with considerable symptom burden and negative effects even in early-stage disease. Patients’ reporting of ADPKD symptom burden may differ from physicians’ impressions. In this quantitative, cross-section survey study, we evaluated patient and physician assessments of symptom burden at early- and late-stage ADPKD. METHODS: In the United States, 300 patients with ADPKD and 155 physicians treating patients with ADPKD completed online surveys administered by Kantar. Disease stage was categorized as early (chronic kidney disease [CKD] stages 1–3) or late (stages 4–5). Patients completed the Work Productivity and Activity Impairment Questionnaire and reported current disease symptoms. Patients and physicians assessed impacts of ADPKD on daily life and burden of specific symptoms. Statistical analyses compared patient versus physician responses stratified by early- versus late-stage ADPKD. RESULTS: We found that impairment in work productivity was statistically greater in late- versus early-stage CKD. Compared with physicians’ impressions, patients were more likely at early stages and less likely at later stages to report a moderate/strong impact of ADPKD on daily life. Among patients, 74% with early- and 88% with late-stage disease reported that ADPKD caused them to modify their daily lives. In early-stage disease, patients reported a statistically greater burden from feeling exhausted and less burden from dull kidney pain, cardiovascular problems, high blood pressure, and liver cysts than physicians assumed. At later stages, patients reported feeling exhausted and skeletal/joint pain as more burdensome, and frequent urination, high blood pressure, liver cysts, and hematuria as less burdensome, compared with physicians’ impressions. CONCLUSION: The results of this survey study demonstrate a disconnect between patients’ experiences and physicians’ awareness of the burden of ADPKD and highlight the need for more patient/physician discussion of symptoms and disease management. Dove 2021-04-13 /pmc/articles/PMC8053527/ /pubmed/33880055 http://dx.doi.org/10.2147/IJNRD.S297491 Text en © 2021 Sanon Aigbogun et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sanon Aigbogun, Myrlene
Oberdhan, Dorothee
Doane, Michael J
Rooney, Jillian
Inyart, Brian C
Pao, Christina S
Denny, Alexis H
Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title_full Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title_fullStr Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title_full_unstemmed Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title_short Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
title_sort disconnect in assessments of autosomal dominant polycystic kidney disease burden between patients and physicians: a survey study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053527/
https://www.ncbi.nlm.nih.gov/pubmed/33880055
http://dx.doi.org/10.2147/IJNRD.S297491
work_keys_str_mv AT sanonaigbogunmyrlene disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT oberdhandorothee disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT doanemichaelj disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT rooneyjillian disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT inyartbrianc disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT paochristinas disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy
AT dennyalexish disconnectinassessmentsofautosomaldominantpolycystickidneydiseaseburdenbetweenpatientsandphysiciansasurveystudy